Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex
Mosaic secured the latest pieces in its medicine combination strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex
James Waldron
Apr 24, 2025 10:00am
Tariffs make M&A decisions 'more difficult,' says Roche CEO
Apr 24, 2025 4:40am
Tempus AI in line for $200M from AstraZeneca cancer model deal
Apr 23, 2025 9:01am
Boehringer slots synthetic lethal program into oncology pipeline
Apr 23, 2025 7:45am
Genentech builds autoimmune Repertoire with $765M deal
Apr 23, 2025 7:00am
Sanofi hands cancer drug to Innate as it pivots R&D pact focus
Apr 23, 2025 6:35am
